Quantitative Renal Uptake Using TC99m DMSA in Hypertensive &/or Diabetic Patients.
NCT ID: NCT03123237
Last Updated: 2017-04-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
45 participants
INTERVENTIONAL
2016-07-31
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
D Tc 99m Dimercaptosuccinic Acid SPECT Versus Planar
NCT04091685
New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney Disease
NCT02250287
Association Between Plasma D Dimer in Adult CAP and Severity of Inflammatory Response and Survival
NCT07199530
Investigation of Urinary Biomarkers for the Diagnosis of Insulin Resistance
NCT04010903
Renal HYPODYSPLASIA : Genetic and Familial Assessment
NCT00925379
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
control will be subjected to:
• Quantitative Tc99m DMSA renal scan using SPECT technique.
DMSA scan
We explore the possible role of DMSA to detect renal affection in diabetic \&/or hypertensive patients by detecting difference in counts using Tc 99m DMSA in control \& diabetic \&/or hypertensive patients.
Diabetic
diabetic cases will be subjected to:
• Quantitative Tc99m DMSA renal scan using SPECT technique.
DMSA scan
We explore the possible role of DMSA to detect renal affection in diabetic \&/or hypertensive patients by detecting difference in counts using Tc 99m DMSA in control \& diabetic \&/or hypertensive patients.
Hypertensive
hypertesive cases will be subjected to:
• Quantitative Tc99m DMSA renal scan using SPECT technique.
DMSA scan
We explore the possible role of DMSA to detect renal affection in diabetic \&/or hypertensive patients by detecting difference in counts using Tc 99m DMSA in control \& diabetic \&/or hypertensive patients.
Diabetic & Hypertensive
Diabetic \& Hypertensive cases will be subjected to:
• Quantitative Tc99m DMSA renal scan using SPECT technique.
DMSA scan
We explore the possible role of DMSA to detect renal affection in diabetic \&/or hypertensive patients by detecting difference in counts using Tc 99m DMSA in control \& diabetic \&/or hypertensive patients.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DMSA scan
We explore the possible role of DMSA to detect renal affection in diabetic \&/or hypertensive patients by detecting difference in counts using Tc 99m DMSA in control \& diabetic \&/or hypertensive patients.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with essential hypertension.
* Patients with diabetes \& hypertension.
* Within normal renal function (urea \& creatinine).
* Control cases may be normal individuals (apparently healthy) like donors for renal transplant.
Exclusion Criteria
* Patients with diseases known to affect kidney function rather diabetes \& hypertension e.g. SLE, heart failure or liver cell failure.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hebat Allah Ahmed Askar
Principle investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assiut university
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DMSA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.